Why the study?
Does two-dimensional and three-dimensional speckle tracking echocardiography detect subclinical myocardial dysfunction in asymptomatic type 1 diabetic patients compared to healthy controls?
Does two-dimensional and three-dimensional speckle tracking echocardiography detect subclinical myocardial dysfunction in asymptomatic type 1 diabetic patients compared to healthy controls?
2D and 3D speckle tracking echocardiography can detect subclinical myocardial dysfunction and its progression in asymptomatic type 1 diabetic patients prior to the onset of clinical heart failure.
May support STE for early detection in asymptomatic type 1 diabetes; hypothesis-generating and should not yet change practice.
No takes yet. Share an insight, caveat, or question.
Ringlé et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: